Published in Life Sci on January 12, 1987
Effects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J Int Soc Sports Nutr (2005) 0.92
Phytochemicals in the Control of Human Appetite and Body Weight. Pharmaceuticals (Basel) (2010) 0.75
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci (1988) 2.27
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res (2000) 1.91
Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav (1985) 1.84
Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol (1976) 1.72
Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci U S A (1993) 1.70
Lipolytic activity of human pituitary fractions on human adipose tissue cells. J Endocrinol (1972) 1.69
Substrate specificity of the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1975) 1.68
Evidence for parathyroid failure in magnesium deficiency. Science (1972) 1.63
Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab (1976) 1.54
The amino acid sequences of the phosphorylated sites in troponin-I from rabbit skeletal muscle. FEBS Lett (1974) 1.49
Clonal sublines that are morphologically and functionally distinct from parental OK cells. Am J Physiol (1989) 1.42
Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol (1997) 1.36
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J Pharmacol Exp Ther (2000) 1.18
Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol (1995) 1.17
Effect of denaturation on the susceptibility of proteins to enzymic phosphorylation. J Biol Chem (1975) 1.17
Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol (1991) 1.15
Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J Pharmacol Exp Ther (1988) 1.14
Esophageal motor function and response to acid perfusion in patients with symptomatic reflux esophagitis. Dig Dis Sci (1985) 1.10
Cowden disease: gene marker studies and measurements of epidermal growth factor. Am J Hum Genet (1986) 1.10
Characterization of human uroguanylin: a member of the guanylin peptide family. Am J Physiol (1994) 1.09
Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity. Proc Natl Acad Sci U S A (1997) 1.07
Pharmacological characterizations of adrenergic receptors in human adipocytes. J Clin Invest (1981) 1.06
Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. Anesthesiology (1992) 1.06
Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. Life Sci (1986) 1.06
Decomposition of phosphoserine and phosphothreonine during acid hydrolysis. Anal Biochem (1976) 1.05
Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J Pharmacol Exp Ther (1991) 1.04
Adrenergic receptors and cyclic AMP in the regulation of human adipose tissue lipolysis. Ann N Y Acad Sci (1971) 1.04
(+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem (1978) 1.04
Lipolysis by human adipose tissue: the role of cyclic 3',5'-adenosine monophosphate and adrenergic receptor sites. J Lab Clin Med (1970) 1.04
Ricinoleic acid effect on the electrical activity of the small intestine in rabbits. J Clin Invest (1978) 1.03
Distribution of heat-stable enterotoxin/guanylin receptors in the intestinal tract of man and other mammals. J Anat (1994) 1.02
Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience (2004) 1.02
Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J (1995) 1.02
Regulation of intestinal Cl- and HCO3-secretion by uroguanylin. Am J Physiol (1998) 1.01
Characterization of the adenyl cyclase of rat kidney plasma membranes. Biochim Biophys Acta (1972) 1.00
Forskolin does not activate sperm adenylate cyclase. Mol Pharmacol (1983) 1.00
Development of the norepinephrine transporter in the rat CNS. Neuroscience (2005) 1.00
Differential effects of neonatal norepinephrine lesions on immediate early gene expression in developing and adult rat brain. Neuroscience (2008) 0.99
Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol (1992) 0.99
Induced myotonia in man and goat. J Lab Clin Med (1965) 0.99
Characterization of alpha 1- and alpha 2-adrenergic receptors. Int Rev Neurobiol (1983) 0.98
Characterization and possible mechanisms of alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. J Biol Chem (1988) 0.98
Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung. J Pharmacol Exp Ther (1982) 0.98
Chest pain and dysphagia in patients with prolonged peristaltic contractile duration of the esophagus. Dig Dis Sci (1984) 0.98
alpha 2-Adrenergic receptors appear in rat salivary glands after reserpine treatment. Nature (1980) 0.97
Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology (1996) 0.96
Postsynaptic localization of alpha 2-adrenergic receptors in rat submandibular gland. J Neurosci (1981) 0.96
Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol (1998) 0.96
Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors. J Clin Invest (1974) 0.96
Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther (1994) 0.95
Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol (1985) 0.95
Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex. J Pharmacol Exp Ther (1985) 0.95
Calcium homeostasis in the laying hen. 1. Age and dietary calcium effects. Poult Sci (1994) 0.95
Secondary achalasia: association with adenocarcinoma of the lung and reversal with radiation therapy. Am J Gastroenterol (1983) 0.95
Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res (1986) 0.95
Colonic motility in the irritable bowel syndrome. Arch Intern Med (1980) 0.94
A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Peptides (1987) 0.94
Opossum colonic mucosa contains uroguanylin and guanylin peptides. Am J Physiol (1996) 0.94
alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther (1983) 0.94
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-EC. Life Sci (1984) 0.94
A simple micromanipulator for multiple uses in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions. J Neurosci Methods (1993) 0.93
A dual mechanism for regulation of kidney phosphate transport by parathyroid hormone. Am J Physiol (1987) 0.93
Progressive secretory dysfunction in the rat submandibular gland after excretory duct ligation. Arch Oral Biol (1982) 0.93
Observations on lipolysis with isolated adipose tissue cells. J Lab Clin Med (1968) 0.92
Independent variation of beta-adrenergic receptor binding and catecholamine-stimulated adenylate cyclase activity in rat erythrocytes. Life Sci (1976) 0.92
Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J Investig Med (1997) 0.91
Opossum kidney contains a functional receptor for the Escherichia coli heat-stable enterotoxin. Biochem Biophys Res Commun (1989) 0.91
Activation of a Cl-dependent K flux by cAMP in pig red cells. Am J Physiol (1989) 0.91
Traumatic hypopituitarism occurring before puberty: survival 35 years untreated. J Clin Endocrinol Metab (1968) 0.91
Myotonic response induced by inhibitors of cholesterol biosynthesis. Science (1966) 0.90
Blood glucose levels during walking in normal and diabetic subjects. Diabetes (1972) 0.89
Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J Pharmacol Exp Ther (1989) 0.89
Measurement and standardization of the gastric pouch in gastric bypass. Surg Gynecol Obstet (1977) 0.89
Lipolytic activity of human pituitary fractions on isolated human adipose-tissue cells. Lancet (1966) 0.89
Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol (1994) 0.89
Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol Pharmacol (1991) 0.89
Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma. Biochem Biophys Res Commun (1996) 0.89
Effect of toxigenic Escherichia coli on myoelectric activity of small intestine. Am J Physiol (1978) 0.89
Insulin inhibition of lipolysis of human adipocytes: the role of cyclic adenosine monophosphate. Diabetes (1979) 0.88
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Mol Pharmacol (1985) 0.88
The role of free fatty acids in the regulation of lipolysis by human adipose tissue cells. Metabolism (1978) 0.88
Adrenergic receptors in human adipocytes--divergent effects of adenosine 3',5'-monophosphate and lipolysis. Biochem Pharmacol (1972) 0.88
Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet (2006) 0.88
Alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production. Proc Natl Acad Sci U S A (1987) 0.88
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. J Pharmacol Exp Ther (1994) 0.87
Renal effects of uroguanylin and guanylin in vivo. Braz J Med Biol Res (1999) 0.87